Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TTR | P02766 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15998074 | 0.86 | PTGS1 (0.43) | CYP3A4TSHRTDP1GABRA1GABRB2 | |
| SCHEMBL6682827 | 0.86 | GABRA1 (0.63) | CYP3A4TSHRTDP1GABRA1GABRB2 | |
| SCHEMBL31075865 | 0.84 | GABRA1 (0.45) | CYP3A4TSHRTDP1GABRA1GABRB2 | |
| SCHEMBL21487683 | 0.84 | ALDH1A1 (0.48) | CYP3A4TSHRTDP1GABRA1GABRB2 | |
| SCHEMBL5911897 | 0.84 | CYP3A4 (0.50) | CYP3A4TSHRTDP1GABRA1GABRB2 | |
| SCHEMBL2986840 | 0.82 | CYP3A4 (0.48) | CYP3A4TSHRTDP1GABRA1GABRB2 | |
| SCHEMBL13219043 | 0.81 | ALOX5 (0.60) | ALOX12ALDH1A1ALOX15MEN1KMT2A | |
| SCHEMBL26229436 | 0.80 | ERN1 (0.58) | GABRA1GABRB2GABRB1KDM4E | |
| SCHEMBL4562076 | 0.78 | ACHE (0.39) | CYP3A4TSHRTDP1GABRA1GABRB2 | |
| SCHEMBL16860588 | 0.78 | APEX1 (0.45) | TDP1GABRA1GABRB2GABRB1ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025230-A | Method for recycling phenolic compounds from epoxy resin-based waste in high yield | 四川大学 | 2025-05-23 | — | — | CN | claimed |
| US-4097547-A | BARIUM CARBONATE, STRONTIUM CARBONATE AND/OR CALCIUM CARBONATE AS STABILIZERS | MOBAY CHEMICAL CORPORATION (US) | 1978-06-27 | — | — | US | claimed |
| CN-120025230-A | Method for recycling phenolic compounds from epoxy resin-based waste in high yield | 四川大学 | 2025-05-23 | — | — | CN | disclosed |
| CN-111454198-B | Compound based on dipyridyl phenol/thiophenol and preparation method and application thereof | 复旦大学 | 2023-02-10 | — | — | CN | disclosed |
| US-10813934-B2 | Sirtuin modulators as inhibitors of cytomegalovirus | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2020-10-27 | — | — | US | disclosed |
| CN-111454198-A | Compound based on dipyridyl phenol/thiophenol and preparation method and application thereof | 复旦大学 | 2020-07-28 | — | — | CN | disclosed |
| US-20190192532-A1 | COMBINATION THERAPY OF BROMODOMAIN INHIBITORS AND CHECKPOINT BLOCKADE | PETER MACCALLUM CANCER INSTITUTE (AU) | 2019-06-27 | — | — | US | disclosed |
| US-10308653-B2 | Diazepane derivatives and uses thereof | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2019-06-04 | — | — | US | disclosed |
| US-20190000860-A1 | USE OF COMPOSITIONS MODULATING CHROMATIN STRUCTURE FOR GRAFT VERSUS HOST DISEASE (GVHD) | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2019-01-03 | — | — | US | disclosed |
| US-10042258-B2 | Composition for forming a resist upper-layer film and method for producing a semiconductor device using the composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-08-07 | — | — | US | disclosed |
| US-20180169097-A1 | COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND KINASE INHIBITORS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2018-06-21 | — | — | US | disclosed |
| US-20020013412-A1 | Flame-retardant resin molding | GENERAL ELECTRIC COMPANY | 2002-01-31 | — | — | US | disclosed |
| WO-2001072905-A2 | FLAME-RETARDANT RESIN MOLDING | GENERAL ELECTRIC COMPANY (US) | 2001-10-04 | — | — | WO | disclosed |
| WO-2001038438-A2 | FLAME-RETARDANT RESIN COMPOSITION AND MOLDED ARTICLE CONSISTING OF THE SAME | GENERAL ELECTRIC COMPANY (US) | 2001-05-31 | — | — | WO | disclosed |
| EP-0306838-A2 | Process of preparing polycarbonates | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1989-03-15 | — | — | EP | disclosed |
| EP-0067857-B1 | THERMOPLASTIC POLYCARBONATE RESINS REINFORCED WITH SILANE TREATED FILLERS | GENERAL ELECTRIC COMPANY (US) | 1986-02-19 | — | — | EP | disclosed |
| EP-0067857-A4 | THERMOPLASTIC POLYCARBONATE RESINS REINFORCED WITH SILANE TREATED FILLERS. | GEN ELECTRIC (US) | 1983-05-16 | — | — | EP | disclosed |
| EP-0067857-A1 | THERMOPLASTIC POLYCARBONATE RESINS REINFORCED WITH SILANE TREATED FILLERS. | GEN ELECTRIC (US) | 1982-12-29 | — | — | EP | disclosed |
| WO-1982002398-A1 | THERMOPLASTIC POLYCARBONATE RESINS REINFORCED WITH SILANE TREATED FILLERS | GEN ELECTRIC (US) | 1982-07-22 | — | — | WO | disclosed |
| US-4131575-A | Thermoplastic polycarbonate molding materials with improved mold release | BAYER AKTIENGESELLSCHAFT (DE) | 1978-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190000860-A1 | USE OF COMPOSITIONS MODULATING CHROMATIN STRUCTURE FOR GRAFT VERSUS HOST DISEASE (GVHD) | BCL6, BCL6B, EZH2 | CYP3A4 4206/4885TSHR 4306/4885TDP1 2409/4885 |
| US-10813934-B2 | Sirtuin modulators as inhibitors of cytomegalovirus | SIRT1, SIRT2, SIRT7 | CYP3A4 4604/4885TSHR 4049/4885TDP1 1937/4885 |
| US-10308653-B2 | Diazepane derivatives and uses thereof | BRDT, BRD4, BAZ2A | CYP3A4 3930/4885TSHR 946/4885TDP1 1097/4885 |
| US-20180169097-A1 | COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND KINASE INHIBITORS | CHUK, BCOR, MYC | CYP3A4 4863/4885TSHR 2021/4885TDP1 662/4885 |
| US-20190192532-A1 | COMBINATION THERAPY OF BROMODOMAIN INHIBITORS AND CHECKPOINT BLOCKADE | BRD4, BRD3, BRPF3 | CYP3A4 4346/4885TSHR 2656/4885TDP1 683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.